Test Price
2,800 AED✅ Home Collection Available
DTNA Gene Left Ventricular Noncompaction 1 (LVNC1) with or without Congenital Heart Defects Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل DTNA الجيني لعدم الانضغاط البطيني الأيسر مع أو بدون عيوب قلبية خلقية في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary (الملخص التنفيذي)
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via NGS processed in an ISO 9001:2015 certified laboratory.
- Premium Logistics: Paid Hospital-Grade Home Collection with ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance and genetic counselling to interpret results.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
فحص جيني دقيق لطفرات DTNA المرتبطة باعتلال عضلة القلب وعدم الانضغاط البطيني بموثوقية تشخيصية 99.9% عبر معالجة معتمدة ISO، مع خدمة سحب منزلي متميزة ومشورة طبية لاحقة.
Overview
The DTNA gene NGS test detects pathogenic variants linked to left ventricular noncompaction (LVNC) and congenital heart defects, aiding in diagnosis, family screening, and personalized management. يتميز هذا التحليل الشامل بدقة عالية ومنهجية تسلسل الجيل التالي مما يوفر نتائج موثوقة لتوجيه الرعاية القلبية والاستشارة الوراثية.
| Feature | Our Test (NGS Panel) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Technology | Next Generation Sequencing (Illumina®) | Sanger Sequencing |
| Analytical Sensitivity | >99.9% for SNVs, indels & CNVs | ~99% (limited to targeted region) |
| Turnaround Time | 3–4 weeks | 2–3 weeks |
| Genomic Coverage | Full coding exons ± 20 bp intronic boundaries | Single exon coverage |
| Clinical Utility | Comprehensive – LVNC, CHD, genotype–phenotype correlation | Limited; may miss deep intronic or large rearrangements |
Physician Insight & Safety Protocol
“I understand that genetic testing for a cardiac condition can bring uncertainty. This DTNA analysis offers clarity for your diagnosis and family planning, but it must always be interpreted alongside your echocardiogram and clinical history. If you experience new symptoms such as palpitations, chest pain or fainting, please seek urgent evaluation. You are not alone – our multidisciplinary team is here to support you.”
— Dr. Prabhakar Reddy, DHA License 61713011
⚠️ Medication Warning:
Do not discontinue any prescribed cardiac medication (e.g., beta‑blockers, ACE inhibitors, antiarrhythmics) without consulting your treating physician. Abrupt cessation may precipitate serious arrhythmias or heart failure.
🚨 Safety & Exclusion Criteria
- Exclusion: Recent whole blood transfusion (<4 weeks) due to donor DNA interference.
- Exclusion: Known interfering medication or chemo/radiotherapy affecting DNA quality.
- ER Red Flags: Sudden severe chest pain, loss of consciousness (syncope), racing heart with dizziness — proceed to nearest emergency department immediately.
- Minors: Genetic testing for children must comply with UAE CDS Law 2026; informed consent from legal guardian is mandatory.
Patient FAQ & Clinical Guidance
Q: What is the DTNA gene test used for?
The DTNA genetic test identifies pathogenic variants causing left ventricular noncompaction and associated congenital heart defects to guide diagnosis and family screening.
يحدد اختبار DTNA الجيني الطفرات المسببة لعدم الانضغاط البطيني الأيسر وعيوب القلب الخلقية المرتبطة لتوجيه التشخيص وفحص أفراد العائلة.
Q: How is the sample collected?
A simple blood draw or dried blood spot card is collected at home by a licensed phlebotomist with cold‑chain transport to maintain DNA integrity.
يتم جمع عينة دم بسيطة أو بقعة دم جافة على بطاقة FTA في المنزل بواسطة ممرض مرخص مع نقلها في سلسلة تبريد للحفاظ على الحمض النووي.
Q: What does a positive result mean?
A positive result indicates a disease-causing variant in DTNA gene that confirms diagnosis and allows cascade testing, but does not predict severity.
تعني النتيجة الإيجابية وجود طفرة ممرضة في جين DTNA تؤكد التشخيص وتتيح فحص أفراد العائلة، لكنها لا تحدد شدة المرض.
Pre‑ Requirements
- A detailed clinical history including echocardiographic findings, family history of LVNC/cardiomyopathy, and previous genetic testing.
- Mandatory genetic counselling session to draw a pedigree chart of affected and at‑risk family members.
- No fasting required; continue all prescribed medications unless advised otherwise.
- Sample types accepted: Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card).
UAE Regulatory & Quality Compliance
Legal Mandates: This service adheres to Federal Decree‑Law No. 41 of 2024 (Article 87 on genetic testing and patient rights), the UAE Child Data Safety (CDS) Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL). All genetic data is stored and processed on secure servers within the UAE with encrypted access.
Accreditation: Laboratory certified ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Facility License: 9834453. Testing methodology aligns with CAP/CLIA standards and 2026 AI-enhanced datasets.
Licensed home collections daily 8 AM – 11 PM | TAT 3–4 weeks | Price: 2,800 AED
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians